Phage therapy for a resistant joint infection
Part of Infections, Injuries & trauma clinical trials.
This trial tests a virus-based treatment (bacteriophage) for a chronic joint infection caused by a specific bacteria that hasn't responded to other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a chronic joint infection that hasn't gone away with previous antibiotic and surgical treatments
- Your infection is caused by a type of bacteria that can be killed by the study viruses in lab tests
- You do not have severe kidney disease (stage 5)
- You do not have liver cirrhosis
- You are not allergic to bacteriophage products
- You are not currently in another clinical trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether bacteriophages—viruses that kill bacteria—can help treat a chronic lung infection caused by a drug-resistant bacterium called Mycobacterium abscessus.
This study tests a new treatment called a phage cocktail (viruses that kill bacteria) for skin infections caused by bacteria that don't respond well to regular antibiotics. The treatment is applied directly to the wound to see if it's safe and effective.
This trial tests a virus-based treatment for a chronic hip or knee implant infection caused by a hard-to-treat bacteria. It is designed as a single-patient study that may help when standard treatments have failed.
This study tests a treatment using viruses (phages) that kill staph bacteria in people with an infected hip or knee replacement. The treatment is given after a surgery to clean the joint, and the goal is to see if it's safe and effective.
This trial studies a new treatment using viruses (phages) that target specific bacteria. If you have a hip or knee joint infection caused by a single type of bacteria (Staph aureus or Pseudomonas) and are having a surgery to clean the joint, this trial may be an option for you.
This trial tests whether specially designed viruses (bacteriophages) can treat infections around orthopedic implants like joint replacements or bone hardware. Bacteriophages are natural virus-like particles that attack bacteria, and this study evaluates whether they are safe and effective when given to patients with hard-to-treat implant infections.
Hear when a new Prosthetic Joint Infections of Hip trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.